GG 296 (Loratadine 10 mg)
Pill imprint GG 296 has been identified as Loratadine 10 mg.
Loratadine is used in the treatment of urticaria; allergic rhinitis and belongs to the drug class antihistamines. There is no proven risk in humans during pregnancy. Loratadine 10 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 10 mg
- 6.00 mm
- Rx and/or OTC
|NDC Code||Manufacturer / Repackager|
|00067-6117||Novartis Pharmaceuticals Corporation|
|00067-6070||Novartis Pharmaceuticals Corporation|
|54569-5497||A-S Medication Solutions, LLC (repackager)|
|23490-9358||Palmetto State Pharmaceuticals Inc (repackager)|
|66336-0422||Dispensing Solutions Inc. (repackager)|
|68258-1056||Dispensing Solutions Inc. (repackager)|
|58016-0800||Southwood Pharmaceuticals Inc (repackager)|
|55289-0728||PDRX Pharmaceuticals Inc (repackager)|
|49999-0229||Lake Erie Medical and Surgical Supply (repackager)|
|16590-0142||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
More about loratadine
- Loratadine capsules
- Loratadine chewable tablets
- Loratadine orally disintegrating tablets
- Loratadine syrup
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.